Delivery Order SPE2DB24D3015-SPE2DB25FFZNZ

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,980.18 firm fixed-price contract is for the supply of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of January 6, 2025. This Delivery Order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560630637 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $1,508.28 and a period of performance through April 19, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $1,381.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, to support military healthcare programs and federal medical institutions. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $2,438.40 and a performance period through June 28, 2024. The contract is a delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.23 firm fixed-price contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a generic cardiovascular medication. The contract has an ultimate completion date of January 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,702.60, is for the delivery of TELMISARTAN 20 MG TABLET 30S, a cardiovascular medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of July 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,124.17 and is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a total ceiling value of $40,017.75 and a completion date of October 21, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S tablets. The contract has a firm fixed price and a ceiling value of $31,058.35, with a performance period ending on January 31, 2025. The contract is not associated with any set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan 40 mg tablets, with a ceiling value of $1,424.67 and a period of performance through March 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZNZ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a medication, with a ceiling value of $1,049.62 and a completion date of May 30, 2025. The contract is a firm-fixed-price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/28/25, 9:53 AM